SPY-PHI

DEVICE2 trials

Sponsors

Massachusetts General Hospital, Matthew Spector

Conditions

Benign NeoplasmMalignant NeoplasmPharyngocutaneous FistulaSquamous Cell Carcinoma

Phase 2

Intraoperative Tumor Margin Identification With ICG Dye Imaging

RecruitingNCT04752137

Massachusetts General HospitalBenign Neoplasm, Malignant Neoplasm

Start: 2022-05-25End: 2030-04-01Target: 100Updated: 2026-04-24

Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction

RecruitingNCT06831149

Matthew SpectorPharyngocutaneous Fistula, Squamous Cell Carcinoma

Start: 2025-02-28End: 2030-02-28Target: 225Updated: 2026-01-09